Group One Trading
NAVB

Group One Trading’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Group One Trading’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-206,900
Closed -$52K – 8552
2022
Q3 		$52K Sell
206,900
-95,600
-32% -$44.6K ﹤0.01% 5384
2022
Q2 		$218K Buy
302,500
+13,200
+5% +$11.2K ﹤0.01% 4220
2022
Q1 		$229K Buy
289,300
+24,300
+9% +$22.3K ﹤0.01% 4656
2021
Q4 		$265K Buy
265,000
+216,600
+448% +$305K ﹤0.01% 4792
2021
Q3 		$85K Buy
48,400
+15,300
+46% +$25.7K ﹤0.01% 6071
2021
Q2 		$61K Buy
33,100
+2,700
+9% +$4.77K ﹤0.01% 6416
2021
Q1 		$61K Sell
30,400
-5,500
-15% -$12.9K ﹤0.01% 6085
2020
Q4 		$77K Buy
35,900
+900
+3% +$2.12K ﹤0.01% 4755
2020
Q3 		$95K Buy
35,000
+31,100
+797% +$112K ﹤0.01% 4227
2020
Q2 		$15K Hold
3,900
– – ﹤0.01% 4975
2020
Q1 		$3K Sell
3,900
-50,000
-93% -$55.2K ﹤0.01% 4939
2019
Q4 		$68K Buy
53,900
+3,900
+8% +$3.37K ﹤0.01% 3868
2019
Q3 		$35K Buy
50,000
+40,000
+400% +$24.6K ﹤0.01% 4155
2019
Q2 		$6K Buy
+10,000
New +$19.4K ﹤0.01% 4586
2017
Q2 		– Sell
-220
Closed -$3K – 5336
2017
Q1 		$3K Sell
220
-1,365
-86% -$15.5K ﹤0.01% 4422
2016
Q4 		$20K Sell
1,585
-1,135
-42% -$18K ﹤0.01% 3708
2016
Q3 		$50K Buy
2,720
+780
+40% +$9.87K ﹤0.01% 3356
2016
Q2 		$21K Sell
1,940
-1,830
-49% -$35.9K ﹤0.01% 3783
2016
Q1 		$71K Buy
3,770
+2,510
+199% +$48.3K ﹤0.01% 3058
2015
Q4 		$34K Buy
1,260
+20
+2% +$695 ﹤0.01% 3642
2015
Q3 		$57K Buy
1,240
+740
+148% +$27.9K ﹤0.01% 3448
2015
Q2 		$16K Hold
500
– – ﹤0.01% 4149
2015
Q1 		$16K Sell
500
-9,855
-95% -$334K ﹤0.01% 3999
2014
Q4 		$391K Sell
10,355
-1,325
-11% -$36.4K 0.01% 1748
2014
Q3 		$308K Buy
11,680
+3,165
+37% +$83.8K ﹤0.01% 2022
2014
Q2 		$252K Sell
8,515
-3,230
-28% -$104K ﹤0.01% 2192
2014
Q1 		$435K Buy
11,745
+4,255
+57% +$161K 0.01% 1750
2013
Q4 		$310K Buy
7,490
+5,815
+347% +$228K ﹤0.01% 2046
2013
Q3 		$89K Sell
1,675
-1,480
-47% -$86.3K ﹤0.01% 3124
2013
Q2 		$168K Buy
+3,155
New +$158K ﹤0.01% 2337

Other funds holding NAVB

BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

Group One Trading's NAVB Position: Q4 2023 in Review

Group One Trading sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q4 2023, closing a stake of 300 shares — an estimated $27 sold.

Group One Trading first reported a position in NAVB in Q2 2013 and held it in 31 quarters. The position peaked at $317K in Q1 2014. 4 funds tracked by Wall St. Rank hold NAVB as of Q4 2023.

  • Group One Trading reported no remaining Navidea Biopharmaceuticals Inc. position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 300 Navidea Biopharmaceuticals Inc. shares in Q4 2023, an estimated $27.
  • Group One Trading first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 31 quarters.
  • Group One Trading's Navidea Biopharmaceuticals Inc. position peaked at $317K in Q1 2014.
  • 4 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.